{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:39:08Z","timestamp":1766137148648,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jaad.2019.01.070","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:45:36Z","timestamp":1549327536000},"page":"902-903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The hydroxychloroquine\u2013interferon gamma release assay question: TB or not TB?"],"prefix":"10.1016","volume":"80","author":[{"given":"Warren R.","family":"Heymann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.01.070_bib1","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaad.2017.01.012","article-title":"Updated recommendations on the use of hydroxychloroquine in dermatology practice","volume":"76","author":"Fernandez","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.01.070_bib2","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3389\/fimmu.2018.02367","article-title":"Immune functional assays, from custom to standardized tests for precision medicine","volume":"9","author":"Albert-Vega","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2019.01.070_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaad.2015.06.004","article-title":"To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis","volume":"73","author":"Ahn","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.01.070_bib4","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells","volume":"24","author":"van den Borne","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2019.01.070_bib5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaad.2018.12.027","article-title":"Evaluating results of an interferon-\u03b3 release assay in patients with autoimmune disease who are taking hydroxychloroquine.","volume":"80","author":"Gaffney","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.01.070_bib6","first-page":"221","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection","volume":"43","author":"Moon","year":"2013","journal-title":"Ann Lab Sci"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219301811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219301811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:48:52Z","timestamp":1759272532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219301811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0190962219301811"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.070","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hydroxychloroquine\u2013interferon gamma release assay question: TB or not TB?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.12.027","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}